Table of Content

1 Study Coverage
1.1 Anti-B1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Anti-B1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global Anti-B1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry
1.3.3 Immunofluorescence
1.3.4 Immunoprecipitation
1.3.5 Western Blot
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-B1 Antibody Sales Estimates and Forecasts 2018-2033
2.2 Global Anti-B1 Antibody Revenue by Region
2.2.1 Global Anti-B1 Antibody Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global Anti-B1 Antibody Revenue by Region (2018-2023)
2.2.3 Global Anti-B1 Antibody Revenue by Region (2024-2033)
2.2.4 Global Anti-B1 Antibody Revenue Market Share by Region (2018-2033)
2.3 Global Anti-B1 Antibody Sales Estimates and Forecasts 2018-2033
2.4 Global Anti-B1 Antibody Sales by Region
2.4.1 Global Anti-B1 Antibody Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global Anti-B1 Antibody Sales by Region (2018-2023)
2.4.3 Global Anti-B1 Antibody Sales by Region (2024-2033)
2.4.4 Global Anti-B1 Antibody Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-B1 Antibody Sales by Manufacturers
3.1.1 Global Anti-B1 Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global Anti-B1 Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-B1 Antibody in 2022
3.2 Global Anti-B1 Antibody Revenue by Manufacturers
3.2.1 Global Anti-B1 Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global Anti-B1 Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Anti-B1 Antibody Revenue in 2022
3.3 Global Key Players of Anti-B1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Anti-B1 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-B1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-B1 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-B1 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Anti-B1 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-B1 Antibody Sales by Type
4.1.1 Global Anti-B1 Antibody Historical Sales by Type (2018-2023)
4.1.2 Global Anti-B1 Antibody Forecasted Sales by Type (2024-2033)
4.1.3 Global Anti-B1 Antibody Sales Market Share by Type (2018-2033)
4.2 Global Anti-B1 Antibody Revenue by Type
4.2.1 Global Anti-B1 Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global Anti-B1 Antibody Forecasted Revenue by Type (2024-2033)
4.2.3 Global Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
4.3 Global Anti-B1 Antibody Price by Type
4.3.1 Global Anti-B1 Antibody Price by Type (2018-2023)
4.3.2 Global Anti-B1 Antibody Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global Anti-B1 Antibody Sales by Application
5.1.1 Global Anti-B1 Antibody Historical Sales by Application (2018-2023)
5.1.2 Global Anti-B1 Antibody Forecasted Sales by Application (2024-2033)
5.1.3 Global Anti-B1 Antibody Sales Market Share by Application (2018-2033)
5.2 Global Anti-B1 Antibody Revenue by Application
5.2.1 Global Anti-B1 Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global Anti-B1 Antibody Forecasted Revenue by Application (2024-2033)
5.2.3 Global Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
5.3 Global Anti-B1 Antibody Price by Application
5.3.1 Global Anti-B1 Antibody Price by Application (2018-2023)
5.3.2 Global Anti-B1 Antibody Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada Anti-B1 Antibody Market Size by Type
6.1.1 US & Canada Anti-B1 Antibody Sales by Type (2018-2033)
6.1.2 US & Canada Anti-B1 Antibody Revenue by Type (2018-2033)
6.2 US & Canada Anti-B1 Antibody Market Size by Application
6.2.1 US & Canada Anti-B1 Antibody Sales by Application (2018-2033)
6.2.2 US & Canada Anti-B1 Antibody Revenue by Application (2018-2033)
6.3 US & Canada Anti-B1 Antibody Market Size by Country
6.3.1 US & Canada Anti-B1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada Anti-B1 Antibody Sales by Country (2018-2033)
6.3.3 US & Canada Anti-B1 Antibody Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-B1 Antibody Market Size by Type
7.1.1 Europe Anti-B1 Antibody Sales by Type (2018-2033)
7.1.2 Europe Anti-B1 Antibody Revenue by Type (2018-2033)
7.2 Europe Anti-B1 Antibody Market Size by Application
7.2.1 Europe Anti-B1 Antibody Sales by Application (2018-2033)
7.2.2 Europe Anti-B1 Antibody Revenue by Application (2018-2033)
7.3 Europe Anti-B1 Antibody Market Size by Country
7.3.1 Europe Anti-B1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe Anti-B1 Antibody Sales by Country (2018-2033)
7.3.3 Europe Anti-B1 Antibody Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-B1 Antibody Market Size
8.1.1 China Anti-B1 Antibody Sales (2018-2033)
8.1.2 China Anti-B1 Antibody Revenue (2018-2033)
8.2 China Anti-B1 Antibody Market Size by Application
8.2.1 China Anti-B1 Antibody Sales by Application (2018-2033)
8.2.2 China Anti-B1 Antibody Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Anti-B1 Antibody Market Size by Type
9.1.1 Asia Anti-B1 Antibody Sales by Type (2018-2033)
9.1.2 Asia Anti-B1 Antibody Revenue by Type (2018-2033)
9.2 Asia Anti-B1 Antibody Market Size by Application
9.2.1 Asia Anti-B1 Antibody Sales by Application (2018-2033)
9.2.2 Asia Anti-B1 Antibody Revenue by Application (2018-2033)
9.3 Asia Anti-B1 Antibody Sales by Region
9.3.1 Asia Anti-B1 Antibody Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia Anti-B1 Antibody Revenue by Region (2018-2033)
9.3.3 Asia Anti-B1 Antibody Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-B1 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-B1 Antibody Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America Anti-B1 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-B1 Antibody Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America Anti-B1 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America Anti-B1 Antibody Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 BosterBio
11.1.1 BosterBio Company Information
11.1.2 BosterBio Overview
11.1.3 BosterBio Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 BosterBio Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BosterBio Recent Developments
11.2 GeneTex
11.2.1 GeneTex Company Information
11.2.2 GeneTex Overview
11.2.3 GeneTex Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GeneTex Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GeneTex Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad Overview
11.3.3 Bio-Rad Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bio-Rad Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bio-Rad Recent Developments
11.4 Leinco Technologies
11.4.1 Leinco Technologies Company Information
11.4.2 Leinco Technologies Overview
11.4.3 Leinco Technologies Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Leinco Technologies Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Leinco Technologies Recent Developments
11.5 MyBioSource
11.5.1 MyBioSource Company Information
11.5.2 MyBioSource Overview
11.5.3 MyBioSource Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 MyBioSource Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 MyBioSource Recent Developments
11.6 RayBiotech
11.6.1 RayBiotech Company Information
11.6.2 RayBiotech Overview
11.6.3 RayBiotech Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 RayBiotech Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 RayBiotech Recent Developments
11.7 Abcam
11.7.1 Abcam Company Information
11.7.2 Abcam Overview
11.7.3 Abcam Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Abcam Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abcam Recent Developments
11.8 Kerafast
11.8.1 Kerafast Company Information
11.8.2 Kerafast Overview
11.8.3 Kerafast Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Kerafast Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kerafast Recent Developments
11.9 Agrisera
11.9.1 Agrisera Company Information
11.9.2 Agrisera Overview
11.9.3 Agrisera Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Agrisera Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Agrisera Recent Developments
11.10 Biorbyt
11.10.1 Biorbyt Company Information
11.10.2 Biorbyt Overview
11.10.3 Biorbyt Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Biorbyt Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Biorbyt Recent Developments
11.11 RevMAb Biosciences USA
11.11.1 RevMAb Biosciences USA Company Information
11.11.2 RevMAb Biosciences USA Overview
11.11.3 RevMAb Biosciences USA Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 RevMAb Biosciences USA Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RevMAb Biosciences USA Recent Developments
11.12 BioLegend
11.12.1 BioLegend Company Information
11.12.2 BioLegend Overview
11.12.3 BioLegend Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 BioLegend Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BioLegend Recent Developments
11.13 Alomone Labs
11.13.1 Alomone Labs Company Information
11.13.2 Alomone Labs Overview
11.13.3 Alomone Labs Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Alomone Labs Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Alomone Labs Recent Developments
11.14 Beijing Solarbio Science & Technology
11.14.1 Beijing Solarbio Science & Technology Company Information
11.14.2 Beijing Solarbio Science & Technology Overview
11.14.3 Beijing Solarbio Science & Technology Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Beijing Solarbio Science & Technology Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Beijing Solarbio Science & Technology Recent Developments
11.15 Wuhan Fine Biotech
11.15.1 Wuhan Fine Biotech Company Information
11.15.2 Wuhan Fine Biotech Overview
11.15.3 Wuhan Fine Biotech Anti-B1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Wuhan Fine Biotech Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Wuhan Fine Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-B1 Antibody Industry Chain Analysis
12.2 Anti-B1 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-B1 Antibody Production Mode & Process
12.4 Anti-B1 Antibody Sales and Marketing
12.4.1 Anti-B1 Antibody Sales Channels
12.4.2 Anti-B1 Antibody Distributors
12.5 Anti-B1 Antibody Customers
13 Market Dynamics
13.1 Anti-B1 Antibody Industry Trends
13.2 Anti-B1 Antibody Market Drivers
13.3 Anti-B1 Antibody Market Challenges
13.4 Anti-B1 Antibody Market Restraints
14 Key Findings in The Global Anti-B1 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-B1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Monoclonal
Table 3. Major Manufacturers of Polyclonal
Table 4. Global Anti-B1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Anti-B1 Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Anti-B1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Anti-B1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 8. Global Anti-B1 Antibody Revenue Market Share by Region (2018-2023)
Table 9. Global Anti-B1 Antibody Revenue Market Share by Region (2024-2033)
Table 10. Global Anti-B1 Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 11. Global Anti-B1 Antibody Sales by Region (2018-2023) & (K Units)
Table 12. Global Anti-B1 Antibody Sales by Region (2024-2033) & (K Units)
Table 13. Global Anti-B1 Antibody Sales Market Share by Region (2018-2023)
Table 14. Global Anti-B1 Antibody Sales Market Share by Region (2024-2033)
Table 15. Global Anti-B1 Antibody Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Anti-B1 Antibody Sales Share by Manufacturers (2018-2023)
Table 17. Global Anti-B1 Antibody Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Anti-B1 Antibody Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Anti-B1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Anti-B1 Antibody Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Anti-B1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-B1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-B1 Antibody as of 2022)
Table 23. Global Key Manufacturers of Anti-B1 Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Anti-B1 Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of Anti-B1 Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 28. Global Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 29. Global Anti-B1 Antibody Sales Share by Type (2018-2023)
Table 30. Global Anti-B1 Antibody Sales Share by Type (2024-2033)
Table 31. Global Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 33. Global Anti-B1 Antibody Revenue Share by Type (2018-2023)
Table 34. Global Anti-B1 Antibody Revenue Share by Type (2024-2033)
Table 35. Anti-B1 Antibody Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Anti-B1 Antibody Price Forecast by Type (2024-2033) & (US$/Unit)
Table 37. Global Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 38. Global Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 39. Global Anti-B1 Antibody Sales Share by Application (2018-2023)
Table 40. Global Anti-B1 Antibody Sales Share by Application (2024-2033)
Table 41. Global Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 43. Global Anti-B1 Antibody Revenue Share by Application (2018-2023)
Table 44. Global Anti-B1 Antibody Revenue Share by Application (2024-2033)
Table 45. Anti-B1 Antibody Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Anti-B1 Antibody Price Forecast by Application (2024-2033) & (US$/Unit)
Table 47. US & Canada Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 49. US & Canada Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 51. US & Canada Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 53. US & Canada Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 55. US & Canada Anti-B1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 56. US & Canada Anti-B1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Anti-B1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 58. US & Canada Anti-B1 Antibody Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Anti-B1 Antibody Sales by Country (2024-2033) & (K Units)
Table 60. Europe Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 61. Europe Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 62. Europe Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 64. Europe Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 65. Europe Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 66. Europe Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 68. Europe Anti-B1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 69. Europe Anti-B1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Anti-B1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 71. Europe Anti-B1 Antibody Sales by Country (2018-2023) & (K Units)
Table 72. Europe Anti-B1 Antibody Sales by Country (2024-2033) & (K Units)
Table 73. China Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 74. China Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 75. China Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 77. China Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 78. China Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 79. China Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 81. Asia Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 82. Asia Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 83. Asia Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 85. Asia Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 86. Asia Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 87. Asia Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 89. Asia Anti-B1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 90. Asia Anti-B1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Anti-B1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 92. Asia Anti-B1 Antibody Sales by Region (2018-2023) & (K Units)
Table 93. Asia Anti-B1 Antibody Sales by Region (2024-2033) & (K Units)
Table 94. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Type (2024-2033) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 98. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Application (2024-2033) & (K Units)
Table 100. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 102. Middle East, Africa and Latin America Anti-B1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-B1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Anti-B1 Antibody Sales by Country (2024-2033) & (K Units)
Table 107. BosterBio Company Information
Table 108. BosterBio Description and Major Businesses
Table 109. BosterBio Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. BosterBio Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. BosterBio Recent Developments
Table 112. GeneTex Company Information
Table 113. GeneTex Description and Major Businesses
Table 114. GeneTex Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. GeneTex Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GeneTex Recent Developments
Table 117. Bio-Rad Company Information
Table 118. Bio-Rad Description and Major Businesses
Table 119. Bio-Rad Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Bio-Rad Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bio-Rad Recent Developments
Table 122. Leinco Technologies Company Information
Table 123. Leinco Technologies Description and Major Businesses
Table 124. Leinco Technologies Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Leinco Technologies Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Leinco Technologies Recent Developments
Table 127. MyBioSource Company Information
Table 128. MyBioSource Description and Major Businesses
Table 129. MyBioSource Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. MyBioSource Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. MyBioSource Recent Developments
Table 132. RayBiotech Company Information
Table 133. RayBiotech Description and Major Businesses
Table 134. RayBiotech Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. RayBiotech Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. RayBiotech Recent Developments
Table 137. Abcam Company Information
Table 138. Abcam Description and Major Businesses
Table 139. Abcam Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Abcam Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Abcam Recent Developments
Table 142. Kerafast Company Information
Table 143. Kerafast Description and Major Businesses
Table 144. Kerafast Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Kerafast Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Kerafast Recent Developments
Table 147. Agrisera Company Information
Table 148. Agrisera Description and Major Businesses
Table 149. Agrisera Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Agrisera Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Agrisera Recent Developments
Table 152. Biorbyt Company Information
Table 153. Biorbyt Description and Major Businesses
Table 154. Biorbyt Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Biorbyt Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Biorbyt Recent Developments
Table 157. RevMAb Biosciences USA Company Information
Table 158. RevMAb Biosciences USA Description and Major Businesses
Table 159. RevMAb Biosciences USA Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. RevMAb Biosciences USA Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. RevMAb Biosciences USA Recent Developments
Table 162. BioLegend Company Information
Table 163. BioLegend Description and Major Businesses
Table 164. BioLegend Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. BioLegend Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. BioLegend Recent Developments
Table 167. Alomone Labs Company Information
Table 168. Alomone Labs Description and Major Businesses
Table 169. Alomone Labs Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Alomone Labs Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Alomone Labs Recent Developments
Table 172. Beijing Solarbio Science & Technology Company Information
Table 173. Beijing Solarbio Science & Technology Description and Major Businesses
Table 174. Beijing Solarbio Science & Technology Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Beijing Solarbio Science & Technology Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Beijing Solarbio Science & Technology Recent Developments
Table 177. Wuhan Fine Biotech Company Information
Table 178. Wuhan Fine Biotech Description and Major Businesses
Table 179. Wuhan Fine Biotech Anti-B1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Wuhan Fine Biotech Anti-B1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Wuhan Fine Biotech Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Anti-B1 Antibody Distributors List
Table 185. Anti-B1 Antibody Customers List
Table 186. Anti-B1 Antibody Market Trends
Table 187. Anti-B1 Antibody Market Drivers
Table 188. Anti-B1 Antibody Market Challenges
Table 189. Anti-B1 Antibody Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-B1 Antibody Product Picture
Figure 2. Global Anti-B1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Anti-B1 Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Anti-B1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Anti-B1 Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry
Figure 9. Immunofluorescence
Figure 10. Immunoprecipitation
Figure 11. Western Blot
Figure 12. ELISA
Figure 13. Others
Figure 14. Anti-B1 Antibody Report Years Considered
Figure 15. Global Anti-B1 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Anti-B1 Antibody Revenue 2018-2033 (US$ Million)
Figure 17. Global Anti-B1 Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 18. Global Anti-B1 Antibody Revenue Market Share by Region (2018-2033)
Figure 19. Global Anti-B1 Antibody Sales 2018-2033 ((K Units)
Figure 20. Global Anti-B1 Antibody Sales Market Share by Region (2018-2033)
Figure 21. US & Canada Anti-B1 Antibody Sales YoY (2018-2033) & (K Units)
Figure 22. US & Canada Anti-B1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 23. Europe Anti-B1 Antibody Sales YoY (2018-2033) & (K Units)
Figure 24. Europe Anti-B1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 25. China Anti-B1 Antibody Sales YoY (2018-2033) & (K Units)
Figure 26. China Anti-B1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Asia (excluding China) Anti-B1 Antibody Sales YoY (2018-2033) & (K Units)
Figure 28. Asia (excluding China) Anti-B1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Anti-B1 Antibody Sales YoY (2018-2033) & (K Units)
Figure 30. Middle East, Africa and Latin America Anti-B1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 31. The Anti-B1 Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-B1 Antibody in the World: Market Share by Anti-B1 Antibody Revenue in 2022
Figure 33. Global Anti-B1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 35. Global Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 36. Global Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 37. Global Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 38. US & Canada Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 39. US & Canada Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 40. US & Canada Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 41. US & Canada Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 42. US & Canada Anti-B1 Antibody Revenue Share by Country (2018-2033)
Figure 43. US & Canada Anti-B1 Antibody Sales Share by Country (2018-2033)
Figure 44. U.S. Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 45. Canada Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 46. Europe Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 47. Europe Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 48. Europe Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 49. Europe Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 50. Europe Anti-B1 Antibody Revenue Share by Country (2018-2033)
Figure 51. Europe Anti-B1 Antibody Sales Share by Country (2018-2033)
Figure 52. Germany Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 53. France Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 54. U.K. Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 55. Italy Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 56. Russia Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 57. China Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 58. China Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 59. China Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 60. China Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 61. Asia Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 62. Asia Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 63. Asia Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 64. Asia Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 65. Asia Anti-B1 Antibody Revenue Share by Region (2018-2033)
Figure 66. Asia Anti-B1 Antibody Sales Share by Region (2018-2033)
Figure 67. Japan Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 68. South Korea Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 69. China Taiwan Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 70. Southeast Asia Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 71. India Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Anti-B1 Antibody Sales Market Share by Type (2018-2033)
Figure 73. Middle East, Africa and Latin America Anti-B1 Antibody Revenue Market Share by Type (2018-2033)
Figure 74. Middle East, Africa and Latin America Anti-B1 Antibody Sales Market Share by Application (2018-2033)
Figure 75. Middle East, Africa and Latin America Anti-B1 Antibody Revenue Market Share by Application (2018-2033)
Figure 76. Middle East, Africa and Latin America Anti-B1 Antibody Revenue Share by Country (2018-2033)
Figure 77. Middle East, Africa and Latin America Anti-B1 Antibody Sales Share by Country (2018-2033)
Figure 78. Brazil Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 79. Mexico Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 80. Turkey Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 81. Israel Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 82. GCC Countries Anti-B1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 83. Anti-B1 Antibody Value Chain
Figure 84. Anti-B1 Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed